FDA Inspection 1181531 — QuVa Pharma, Inc.
The FDA completed an inspection of QuVa Pharma, Inc. on Oct 14, 2022 in Bloomsbury, NJ. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Oct 14, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Bloomsbury, NJ (United States)